ClinicalTrials.govpublic full text
Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease
nonalcoholic fatty liver disease, pioglitazone, berberine, impaired glucose metabolism, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 892924
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.